Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy

Wei Sun,1 Meng Gao,2 Guangyuan Hu,1 Xun Yuan1 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of China; 2Department of Medical Ultrasound, Tongji Hospital of Tongji Medical College, Hu...

Full description

Bibliographic Details
Main Authors: Sun W, Gao M, Hu G, Yuan X
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Cancer Management and Research
Subjects:
ldh
Online Access:https://www.dovepress.com/inflammatory-marker-predicts-outcome-of-oral-squamous-cell-carcinoma-r-peer-reviewed-article-CMAR
id doaj-09bd0d624f8c4b68990a5773abe5e7e5
record_format Article
spelling doaj-09bd0d624f8c4b68990a5773abe5e7e52020-12-01T19:57:43ZengDove Medical PressCancer Management and Research1179-13222020-12-01Volume 12123291233559840Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-RadiotherapySun WGao MHu GYuan XWei Sun,1 Meng Gao,2 Guangyuan Hu,1 Xun Yuan1 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of China; 2Department of Medical Ultrasound, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of ChinaCorrespondence: Xun YuanDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei, People’s Republic of ChinaTel +86-027-8366-3406Fax +86-027-8366-3630Email yuanxun@tjh.tjmu.edu.cnBackground: Inflammation is involved in the progression of oral squamous cell carcinoma. We therefore postulate that a blood-based inflammatory marker, the neutrophil-to-lymphocyte ratio, could help to predict the prognosis in patients with oral squamous cell carcinoma receiving chemo-radiotherapy, and build a prognostic nomogram.Methods: In 111 cases of oral squamous cell carcinoma, several baseline variables, including inflammatory markers and lactate dehydrogenase, were measured within the week of chemo-radiotherapy initiation as predictors of mortality and separate risk scores were developed.Results: Dichotomized neutrophil-to-lymphocyte ratio was found to be associated with AJCC stage (p< 0.001). Patients with oral squamous cell carcinoma with a low neutrophil-to-lymphocyte ratio survived longer than those with a high neutrophil-to-lymphocyte ratio (overall survival HR=2.39, 95% CI 1.24– 4.61, p=0.009). The Harrell’s concordance (C)-statistic of the nomogram was 0.74 and the calibration curve demonstrated the goodness of fit.Conclusion: The inflammatory marker neutrophil-to-lymphocyte ratio, obtained before chemo-radiotherapy, was an independent factor of survival prediction for oral squamous cell carcinoma. The nomogram incorporating immunological markers could more accurately predict individualized survival probability than the existing models. These findings are significant for the creation of personalized treatment strategies in the clinical setting.Keywords: nomogram, oral squamous cell carcinoma, LDH, platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratiohttps://www.dovepress.com/inflammatory-marker-predicts-outcome-of-oral-squamous-cell-carcinoma-r-peer-reviewed-article-CMARnomogramoral squamous cell carcinomaldhplatelet-to-lymphocyte rationeutrophil-to-lymphocyte ratio
collection DOAJ
language English
format Article
sources DOAJ
author Sun W
Gao M
Hu G
Yuan X
spellingShingle Sun W
Gao M
Hu G
Yuan X
Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy
Cancer Management and Research
nomogram
oral squamous cell carcinoma
ldh
platelet-to-lymphocyte ratio
neutrophil-to-lymphocyte ratio
author_facet Sun W
Gao M
Hu G
Yuan X
author_sort Sun W
title Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy
title_short Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy
title_full Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy
title_fullStr Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy
title_full_unstemmed Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy
title_sort inflammatory marker predicts outcome of oral squamous cell carcinoma receiving chemo-radiotherapy
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2020-12-01
description Wei Sun,1 Meng Gao,2 Guangyuan Hu,1 Xun Yuan1 1Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of China; 2Department of Medical Ultrasound, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430020, Hubei, People’s Republic of ChinaCorrespondence: Xun YuanDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei, People’s Republic of ChinaTel +86-027-8366-3406Fax +86-027-8366-3630Email yuanxun@tjh.tjmu.edu.cnBackground: Inflammation is involved in the progression of oral squamous cell carcinoma. We therefore postulate that a blood-based inflammatory marker, the neutrophil-to-lymphocyte ratio, could help to predict the prognosis in patients with oral squamous cell carcinoma receiving chemo-radiotherapy, and build a prognostic nomogram.Methods: In 111 cases of oral squamous cell carcinoma, several baseline variables, including inflammatory markers and lactate dehydrogenase, were measured within the week of chemo-radiotherapy initiation as predictors of mortality and separate risk scores were developed.Results: Dichotomized neutrophil-to-lymphocyte ratio was found to be associated with AJCC stage (p< 0.001). Patients with oral squamous cell carcinoma with a low neutrophil-to-lymphocyte ratio survived longer than those with a high neutrophil-to-lymphocyte ratio (overall survival HR=2.39, 95% CI 1.24– 4.61, p=0.009). The Harrell’s concordance (C)-statistic of the nomogram was 0.74 and the calibration curve demonstrated the goodness of fit.Conclusion: The inflammatory marker neutrophil-to-lymphocyte ratio, obtained before chemo-radiotherapy, was an independent factor of survival prediction for oral squamous cell carcinoma. The nomogram incorporating immunological markers could more accurately predict individualized survival probability than the existing models. These findings are significant for the creation of personalized treatment strategies in the clinical setting.Keywords: nomogram, oral squamous cell carcinoma, LDH, platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio
topic nomogram
oral squamous cell carcinoma
ldh
platelet-to-lymphocyte ratio
neutrophil-to-lymphocyte ratio
url https://www.dovepress.com/inflammatory-marker-predicts-outcome-of-oral-squamous-cell-carcinoma-r-peer-reviewed-article-CMAR
work_keys_str_mv AT sunw inflammatorymarkerpredictsoutcomeoforalsquamouscellcarcinomareceivingchemoradiotherapy
AT gaom inflammatorymarkerpredictsoutcomeoforalsquamouscellcarcinomareceivingchemoradiotherapy
AT hug inflammatorymarkerpredictsoutcomeoforalsquamouscellcarcinomareceivingchemoradiotherapy
AT yuanx inflammatorymarkerpredictsoutcomeoforalsquamouscellcarcinomareceivingchemoradiotherapy
_version_ 1724410688122650624